ADORA2A and small cell lung carcinoma: Here, we aim to determine whether and how the adenosine/ADORA2A signaling is involved in the acquisition of the NE transcriptional signature and maintenance of the NE phenotype in NEPC and small cell lung cancer (SCLC).